News

04 January 2017

Richard Kirk is CEO of a County Durham-based medical technology company that has developed a non-invasive treatment to prevent, treat and even reverse blindness in diabetics – potentially saving the NHS hundreds of millions of pounds. His career can best be described as unorthodox, as Alison Cowie discovers

Read more →


12 October 2016

A County Durham firm behind revolutionary blindness treatment is plotting further global expansion as strong transatlantic demand bolsters its market standing, The Northern Echo can reveal. To raise awareness of its treatment, PolyPhotonix is holding an open evening in Darlington next week, where diabetes patients can find out more about Noctura 400.

Read more →


10 October 2016

Hear from a person currently using Noctura 400, learn how the treatment works and an opportunity to ask any questions you may have. Attendees receive 20% off their first mask if they decide to go ahead with the treatment.

Read more →


14 June 2016

New survey reveals that more than 50% of diabetes patients have experienced sight-related issues

Read more →


26 May 2016

A man has signed up to do the Great North Run blindfolded to raise money for an eye charity after watching his mum lose her sight.

Read more →


24 May 2016

PolyPhotonix have been named by The Journal as one of the top 50 North East tech companies driving the digital revolution.

Read more →


26 April 2016

A County Durham firm is taking blindness prevention treatment to the US and Asia in a move bosses hope will double their workforce.

Read more →


25 April 2016

Durham County Council has made a £300,000 investment into NetPark business PolyPhotonix

Read more →


20 April 2016

NECC members heard an inspirational presentation at CPI on NETPark in Sedgefield last week which is a great success story for the region, writes James Ramsbotham, NECC chief executive .

Read more →


01 April 2016

Innovate UK, the people who funded the development of Noctura 400, have published a new video about the revolutionary treatment for degenerative sight-threatening conditions caused by age and diabetes.

Read more →


Page 1 of 7 Next